Malaria Transmission Biology
Our research has led to the discovery of a mosquito-based malaria transmission-blocking vaccine (TBV) candidate (the AnAPN1 TBV), which has recently completed process development studies and is under consideration for First-In-Human trials in the near future.
[Pictured: Plasmodium falciparum male gamete "exflagellating"]